• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OV 632和MOC 31在间皮瘤和腺癌诊断中的应用:对其在福尔马林固定石蜡包埋材料中应用的评估

OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.

作者信息

Edwards C, Oates J

机构信息

Department of Histopathology, Birmingham Heartlands Hospital.

出版信息

J Clin Pathol. 1995 Jul;48(7):626-30. doi: 10.1136/jcp.48.7.626.

DOI:10.1136/jcp.48.7.626
PMID:7560168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC502712/
Abstract

AIMS

To investigate the reaction of antibodies OV 632 and MOC 31 in paraffin wax sections as opposed to frozen sections and cytological preparations; to evaluate their usefulness in the differential diagnosis of malignant mesothelioma and secondary adenocarcinoma of the pleura; and to assess the efficacy of microwave pretreatment of sections in unmasking their associated epitopes.

METHODS

Immunohistochemistry, using a standard avidin-biotin technique, with microwave pretreatment and trypsinisation in a certain proportion of cases. The material comprised 43 mesotheliomas, 44 adenocarcinomas and five reactive pleuras.

RESULTS

Epithelial mesotheliomas and the hyperplastic mesothelial cells reacted strongly with OV 632, the reaction with sarcomatoid and desmoplastic tumours was weak, and the reaction with adenocarcinomas was variable. An unequivocal but sometimes patchy positive reaction was obtained with MOC 31 in all but one of the adenocarcinomas; all but one of the mesotheliomas and all the reactive pleuras were negative. Review of the two apparently anomalous cases revealed that the original diagnoses had probably been incorrect. Reactions to both antibodies were abolished by microwave pretreatment, and also by prior trypsinisation in the case of OV 632.

CONCLUSIONS

OV 632 is unsuitable for routine clinical use in paraffin wax embedded material. MOC 31, however, would be a useful addition to a panel of antibodies in the differential diagnosis of mesothelioma and adenocarcinoma in large biopsy and resection specimens and necropsy material. Its value in small biopsy specimens remains to be assessed. Microwave pretreatment does not enhance the reactions with either antibody.

摘要

目的

研究抗体OV 632和MOC 31在石蜡切片中的反应,与冰冻切片和细胞学标本中的反应进行对比;评估它们在恶性间皮瘤和胸膜继发性腺癌鉴别诊断中的作用;并评估切片微波预处理在暴露相关抗原决定簇方面的效果。

方法

采用标准抗生物素蛋白-生物素技术进行免疫组织化学检测,部分病例进行微波预处理和胰蛋白酶消化处理。材料包括43例间皮瘤、44例腺癌和5例反应性胸膜组织。

结果

上皮性间皮瘤和增生的间皮细胞与OV 632反应强烈,与肉瘤样和促纤维增生性肿瘤反应较弱,与腺癌的反应则各不相同。除1例腺癌外,所有腺癌与MOC 31均呈现明确但有时呈斑片状的阳性反应;除1例间皮瘤外,所有间皮瘤和所有反应性胸膜均为阴性。对这两例明显异常的病例复查显示,最初的诊断可能有误。微波预处理以及对OV 632而言先进行胰蛋白酶消化处理,均可消除两种抗体的反应。

结论

OV 632不适用于石蜡包埋材料的常规临床应用。然而,MOC 31在大活检和切除标本以及尸检材料中间皮瘤和腺癌的鉴别诊断中,作为一组抗体的补充将很有用。其在小活检标本中的价值仍有待评估。微波预处理不会增强与任何一种抗体的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af87/502712/196bad40fb2c/jclinpath00232-0034-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af87/502712/e74de65be7d4/jclinpath00232-0033-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af87/502712/504f4e930165/jclinpath00232-0033-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af87/502712/196bad40fb2c/jclinpath00232-0034-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af87/502712/e74de65be7d4/jclinpath00232-0033-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af87/502712/504f4e930165/jclinpath00232-0033-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af87/502712/196bad40fb2c/jclinpath00232-0034-a.jpg

相似文献

1
OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.OV 632和MOC 31在间皮瘤和腺癌诊断中的应用:对其在福尔马林固定石蜡包埋材料中应用的评估
J Clin Pathol. 1995 Jul;48(7):626-30. doi: 10.1136/jcp.48.7.626.
2
HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma.HBME-1、MOC-31、WT1和钙视网膜蛋白:对近期描述的间皮瘤和腺癌标志物的评估
Histopathology. 2000 Apr;36(4):341-7. doi: 10.1046/j.1365-2559.2000.00770.x.
3
MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells.MOC-31有助于鉴别腺癌和反应性间皮细胞。
Cancer. 1999 Dec 25;87(6):390-4. doi: 10.1002/(sici)1097-0142(19991225)87:6<390::aid-cncr10>3.0.co;2-4.
4
Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.福尔马林固定、石蜡包埋组织中N-钙黏蛋白在胸膜间皮瘤中的差异表达及E-钙黏蛋白在肺腺癌中的差异表达。
Hum Pathol. 1997 Jun;28(6):641-5. doi: 10.1016/s0046-8177(97)90171-4.
5
Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.MOC-31单克隆抗体在鉴别上皮性胸膜间皮瘤与肺腺癌中的价值。
Hum Pathol. 1998 Feb;29(2):166-9. doi: 10.1016/s0046-8177(98)90227-1.
6
The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.间皮瘤的免疫组化诊断。间皮瘤与肺腺癌的鉴别。
Am J Surg Pathol. 1989 Apr;13(4):276-91.
7
Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura.联合使用新型上皮(MOC-31)和间皮(HBME-1)免疫组化标志物,以实现胸膜间皮瘤与转移性癌的最佳一线诊断区分。
Histopathology. 2001 Jun;38(6):528-34. doi: 10.1046/j.1365-2559.2001.01157.x.
8
Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.免疫组织化学在恶性间皮瘤与肺腺癌鉴别诊断中的应用:对新型抗体的批判性评估
J Clin Pathol. 2002 Sep;55(9):662-8. doi: 10.1136/jcp.55.9.662.
9
Diagnostic tools for differentiating between pleural mesothelioma and lung adenocarcinoma in paraffin embedded tissue. Part I: Immunohistochemical findings.石蜡包埋组织中鉴别胸膜间皮瘤和肺腺癌的诊断工具。第一部分:免疫组化结果。
Virchows Arch A Pathol Anat Histopathol. 1993;423(1):19-27. doi: 10.1007/BF01606427.
10
Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology?细胞恶性与良性:体液细胞学中“新型”标志物的作用有多大?
Arch Pathol Lab Med. 2008 Jan;132(1):23-8. doi: 10.5858/2008-132-23-CMVBHU.

引用本文的文献

1
Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis.恶性上皮性间皮瘤的免疫表型分析及其在鉴别诊断中的作用。
J Huazhong Univ Sci Technolog Med Sci. 2004;24(2):112-5. doi: 10.1007/BF02885405.
2
Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages.MOC-31和HBME-1免疫组化在腺癌与恶性间皮瘤鉴别诊断中的特异性:对来自土耳其村庄的环境性恶性间皮瘤病例的研究
Pathol Oncol Res. 2002;8(3):188-93. doi: 10.1007/BF03032393. Epub 2003 Jan 6.
3

本文引用的文献

1
The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma.寻找用于诊断恶性间皮瘤的最佳免疫组化组合。
Hum Pathol. 1993 Apr;24(4):345-6. doi: 10.1016/0046-8177(93)90079-v.
2
Immunocytochemistry in the differential diagnosis of effusions: use of logistic regression to select a panel of antibodies to distinguish adenocarcinomas from mesothelial proliferations.免疫细胞化学在积液鉴别诊断中的应用:利用逻辑回归选择一组抗体以区分腺癌与间皮增生。
Mod Pathol. 1993 Mar;6(2):179-84.
3
Immunopathology of malignant mesothelioma.
HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.
HBME-1和抗凝血酶调节蛋白在胸膜恶性间皮瘤鉴别诊断中的应用
J Clin Pathol. 1997 Oct;50(10):859-62. doi: 10.1136/jcp.50.10.859.
4
Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.恶性间皮瘤、肺腺癌和大细胞间变性肺癌中DNA拷贝数变化的比较。
Br J Cancer. 1998;77(2):260-9. doi: 10.1038/bjc.1998.42.
恶性间皮瘤的免疫病理学
Hum Pathol. 1994 Mar;25(3):219-20. doi: 10.1016/0046-8177(94)90190-2.
4
Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells.
Arch Pathol Lab Med. 1994 Mar;118(3):265-9.
5
Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.区分恶性胸膜间皮瘤与肺腺癌的多标记免疫组化表型
Hum Pathol. 1993 Apr;24(4):347-54. doi: 10.1016/0046-8177(93)90080-z.
6
Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies.免疫细胞化学中的微波抗原修复:80种抗体的研究
J Clin Pathol. 1994 May;47(5):448-52. doi: 10.1136/jcp.47.5.448.
7
Immunohistological characterization of a monoclonal antibody (OV632) against epithelial ovarian carcinomas.
Virchows Arch A Pathol Anat Histopathol. 1987;410(6):481-6. doi: 10.1007/BF00781682.
8
Pleural malignant mesothelioma following Wilms' tumor.肾母细胞瘤后发生的胸膜恶性间皮瘤。
Am J Clin Pathol. 1986 Aug;86(2):227-30. doi: 10.1093/ajcp/86.2.227.
9
Pathology of human mesothelioma. Etiologic and diagnostic considerations.人类间皮瘤的病理学。病因学及诊断考量
Pathol Annu. 1987;22 Pt 2:91-131.
10
Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.恶性间皮瘤的免疫细胞化学:OV632作为恶性间皮瘤的标志物
J Pathol. 1991 Oct;165(2):137-43. doi: 10.1002/path.1711650209.